BR112022020776A2 - Pirrolo[1,2-d][1,2,4]triazina-2-il-acetamidas como inibidores da via do inflamassoma de nlrp3 - Google Patents

Pirrolo[1,2-d][1,2,4]triazina-2-il-acetamidas como inibidores da via do inflamassoma de nlrp3

Info

Publication number
BR112022020776A2
BR112022020776A2 BR112022020776A BR112022020776A BR112022020776A2 BR 112022020776 A2 BR112022020776 A2 BR 112022020776A2 BR 112022020776 A BR112022020776 A BR 112022020776A BR 112022020776 A BR112022020776 A BR 112022020776A BR 112022020776 A2 BR112022020776 A2 BR 112022020776A2
Authority
BR
Brazil
Prior art keywords
inhibitors
pyrolo
triazine
pathway
acetamides
Prior art date
Application number
BR112022020776A
Other languages
English (en)
Inventor
Oehlrich Daniel
Luc Maria Van Gool Michiel
Van Opdenbosch Nina
Lamkanfi Mohamed
Elisabeth Leenaerts Joseph
Manuel Martinez Viturro Carlos
Eric Muratore Michael
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of BR112022020776A2 publication Critical patent/BR112022020776A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Abstract

PIRROLO[1,2-D][1,2,4]TRIAZINA-2-ILACETAMIDAS COMO INIBIDORES DA VIA DO INFLAMASSOMA DE NLRP3. A presente invenção refere-se a compostos para uso como inibidores da produção de inflamassoma de NLRP3, em que tais compostos são conforme definidos pelos compostos da fórmula (I) e em que os números inteiros R1, R2 e R3 são definidos na descrição, e em que os compostos podem ser úteis como medicamentos, por exemplo, para uso no tratamento de uma doença ou transtorno que é associado à atividade de inflamassoma de NLRP3.
BR112022020776A 2020-04-15 2021-04-15 Pirrolo[1,2-d][1,2,4]triazina-2-il-acetamidas como inibidores da via do inflamassoma de nlrp3 BR112022020776A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20382298 2020-04-15
PCT/EP2021/059755 WO2021209539A1 (en) 2020-04-15 2021-04-15 Pyrrolo[1,2-d][1,2,4]triazine-2-yl-acetamides as inhibitors of the nlrp3 inflammasome pathway

Publications (1)

Publication Number Publication Date
BR112022020776A2 true BR112022020776A2 (pt) 2022-11-29

Family

ID=70391033

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022020776A BR112022020776A2 (pt) 2020-04-15 2021-04-15 Pirrolo[1,2-d][1,2,4]triazina-2-il-acetamidas como inibidores da via do inflamassoma de nlrp3

Country Status (10)

Country Link
US (1) US20230183248A1 (pt)
EP (1) EP4135842A1 (pt)
JP (1) JP2023521242A (pt)
KR (1) KR20230002652A (pt)
CN (1) CN115485026A (pt)
AU (1) AU2021255895A1 (pt)
BR (1) BR112022020776A2 (pt)
CA (1) CA3174829A1 (pt)
MX (1) MX2022012896A (pt)
WO (1) WO2021209539A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114478537B (zh) * 2020-11-13 2024-02-02 上海拓界生物医药科技有限公司 环酰胺并环化合物及其医药用途
WO2023118521A1 (en) 2021-12-22 2023-06-29 Ac Immune Sa Dihydro-oxazol derivative compounds
WO2024013395A1 (en) 2022-07-14 2024-01-18 Ac Immune Sa Pyrrolotriazine and imidazotriazine derivatives as modulators of the nlrp3 inflammasome pathway
WO2024023266A1 (en) 2022-07-28 2024-02-01 Ac Immune Sa Novel compounds
WO2024064655A1 (en) * 2022-09-20 2024-03-28 BioAge Labs, Inc. Indazole and pyrazolopyridine compounds as inhibitors of nlrp3 inflammasome
WO2024064245A1 (en) 2022-09-23 2024-03-28 Merck Sharp & Dohme Llc Phthalazine derivatives useful as inhibitors of nod-like receptor protein 3
CN116023296B (zh) * 2022-12-29 2023-07-07 上海国创医药股份有限公司 一种马来酸氟伏沙明的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7157804B2 (ja) 2017-10-17 2022-10-20 ノバルティス アーゲー Ｎｌｒｐ活性に関連する病態を治療するためのスルホンアミド及びその組成物
GB201721185D0 (en) 2017-12-18 2018-01-31 Nodthera Ltd Sulphonyl urea derivatives
GB201803393D0 (en) 2018-03-02 2018-04-18 Inflazome Ltd Novel compounds
WO2020010143A1 (en) 2018-07-03 2020-01-09 Novartis Inflammasome Research, Inc. Nlrp modulators
CA3105521A1 (en) 2018-07-20 2020-01-23 F. Hoffmann-La Roche Ag Sulfonimidamide compounds as inhibitors of interleukin-1 activity
US20210308140A1 (en) 2018-07-25 2021-10-07 Novartis Ag Nlrp3 inflammasome inhibitors
WO2020037116A1 (en) 2018-08-17 2020-02-20 H. Lee Moffitt Cancer Center And Research Institute, Inc. Small molecule pyrin-domain targeted nlrp3 inflammasome inhibitors

Also Published As

Publication number Publication date
CA3174829A1 (en) 2021-10-21
CN115485026A (zh) 2022-12-16
EP4135842A1 (en) 2023-02-22
JP2023521242A (ja) 2023-05-23
US20230183248A1 (en) 2023-06-15
KR20230002652A (ko) 2023-01-05
MX2022012896A (es) 2022-11-09
WO2021209539A1 (en) 2021-10-21
AU2021255895A1 (en) 2022-12-15

Similar Documents

Publication Publication Date Title
BR112022020776A2 (pt) Pirrolo[1,2-d][1,2,4]triazina-2-il-acetamidas como inibidores da via do inflamassoma de nlrp3
BR112022023271A2 (pt) Compostos
BR112022020807A2 (pt) Pirazolo[1,5-d][1,2,4]triazina-5(4h)-acetamidas como inibidores da trajetória de inflamassoma de nlrp3
BR112022020798A2 (pt) Compostos tricíclicos como inibidores de nlrp3
BR112022021881A2 (pt) Novos compostos de triazinoindol
BR112021022778A2 (pt) Compostos e métodos para o tratamento de covid-19
BRPI0513086A (pt) 8-pirrolidinoxantinas bicìclicas substituìdas, processo para a produção das mesmas e seu uso como medicamentos
BR112013003097A2 (pt) 6-cicloalquil-pirazolopirimidemonas para o tratamento de distúrbio de cns
ECSP22087539A (es) Inhibidores de kras tricíclicos fusionados
BR112015028879A8 (pt) compostos derivados heterocíclicos, composição farmacêutica compreendendo os referidos compostos e usos dos mesmos
BR112023015527A2 (pt) Inibidores de cdk e métodos de uso destes
BR112012030024A2 (pt) compostos, processo para a preparação de um composto, medicamento
BR112017012327A8 (pt) benzamidas substituídas por 1,3-tiazol-2-il.
BR112014008045A2 (pt) benzilindazóis substituídos para uso como inibidores de bub1 cinase no tratamento de doenças hiperproliferativas
BR112012027062A2 (pt) composto, processo para a preparação de um composto, método para prevenção e/ou tratamento de doenças e condições, e, composição farmacêutica
BR112016005881A2 (pt) composto, composição farmacêutica e uso do composto
BR112013011634A2 (pt) derivados de 2,3-di-hidroimidazol[1,2-c]quinazolina substituídos por aminoálcool úteis para tratar os distúrbios hiperproliferativos e as doenças associadas com a angiogênese derivados de 2,3-di-hidroimidazol[1,2-c]
BRPI0514692A (pt) inibidores do receptor sigma
BRPI0607927A2 (pt) derivados de pirazol-pirimidina
BR112022010112A2 (pt) Aminoquinolonas substituídas como inibidores de dgkalfa para ativação imunológica
BR112013020605A2 (pt) derivados de 6-ciclobutil-1,5-diidro-pirazol[3,4-d]pirimidin-4-ona e seu uso como inibidores de pde9a
BR112022024045A2 (pt) Moduladores il-17a
BR112022023983A2 (pt) Compostos terapêuticos
BR112021026820A2 (pt) Inibidores heterocíclicos de monoacilglicerol lipase (magl)
BR112023001538A2 (pt) Compostos antagonistas